Status:

RECRUITING

Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Neonatal Late Onset Sepsis

Eligibility:

All Genders

7-14 years

Brief Summary

Late-onset neonatal sepsis (LOS), occurring in newborn of at least 7 days of life, is frequently observed in Neonatal Intensive Care Units (NICUs) and potentially severe (mortality, neurologic and res...

Eligibility Criteria

Inclusion

  • Patient hospitalized in the NICU of one of the two recruiting centers at the time of inclusion
  • Patients aged ≥ 7 days
  • Patients weighted ≥ 500 g the day of blood sample
  • patients with suggestive signs of LOS including at least one of the following:Fever \> 38°C; tachycardia \> 160bpm; capillary refill time \> 3 seconds; grey and/or pale skin complexion; apnea/ bradycardia syndrome, bloating; vomiting; rectal bleeding; hypotonia; lethargy; seizures without other obvious cause; increased ventilatory support and/or increased FiO2; cutaneous rash; inflammation at the needle-puncture site of the central venous catheter; or any other condition for which the clinician suspected an infection
  • patients with a standard of care blood sampling, including at least a blood culture;

Exclusion

  • Patient treated with antibiotics for a bacteriologically confirmed infection at the time of sampling or within 48 hours prior to sampling
  • Patient who underwent surgery within the previous 7 days
  • Patients vaccinated within the previous 7 days
  • Patient who received treatment with systemic corticosteroid therapy in the 48 hours prior to sampling
  • Patient with severe combined immunodeficiency
  • Opposition from parent(s)/guardian(s)

Key Trial Info

Start Date :

November 22 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

358 Patients enrolled

Trial Details

Trial ID

NCT06058819

Start Date

November 22 2023

End Date

May 1 2027

Last Update

September 3 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

neonatal Intensive care unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, France

Bron, France, 69500

2

Hôpital Couple-Enfant - CHU Grenoble Alpes

Grenoble, France, 38700

3

Neonatal intensive care unit, Hôpital femme-maternité

Nantes, France, 44300

Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS | DecenTrialz